文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System.

作者信息

Hwang Stephanie S, Takata Mark C, Fujioka Ken, Fuller William

机构信息

Division of General/Bariatric Surgery, Scripps Clinic Weight Management.

Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA, USA.

出版信息

Med Devices (Auckl). 2016 Aug 17;9:291-9. doi: 10.2147/MDER.S106223. eCollection 2016.

DOI:10.2147/MDER.S106223
PMID:27574473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4993556/
Abstract

There are many different methods of treating obesity, ranging from various medical options to several surgical therapies. This paper briefly summarizes current surgical options for weight loss with a focus on one of the newest US Food and Drug Administration-approved devices for surgical weight loss therapy, the Maestro Rechargeable System. Also known as the vagal blocking for obesity control implantable device, this tool blocks vagal nerve activity to induce weight loss.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/aab5283b6f06/mder-9-291Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/169db73833ea/mder-9-291Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/416fce957247/mder-9-291Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/508dd2e1ccf4/mder-9-291Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/1b7f2498f39f/mder-9-291Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/0a54ef2978ff/mder-9-291Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/76a0acbf65e4/mder-9-291Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/13e57e413598/mder-9-291Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/aab5283b6f06/mder-9-291Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/169db73833ea/mder-9-291Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/416fce957247/mder-9-291Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/508dd2e1ccf4/mder-9-291Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/1b7f2498f39f/mder-9-291Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/0a54ef2978ff/mder-9-291Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/76a0acbf65e4/mder-9-291Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/13e57e413598/mder-9-291Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dc/4993556/aab5283b6f06/mder-9-291Fig8.jpg

相似文献

[1]
Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System.

Med Devices (Auckl). 2016-8-17

[2]
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study.

Obes Surg. 2016-5

[3]
Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial.

Obes Surg. 2017-1

[4]
Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action.

Obes Surg. 2017-1

[5]
Devices and Endoscopic Bariatric Therapies for Obesity.

Curr Obes Rep. 2018-6

[6]
Laparoscopic vagal nerve blocking device explantation: case series and report of operative technique.

Surg Endosc. 2019-1-10

[7]
Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

Surgery. 2008-6

[8]
Letter to the Editor: Vagal Blocking (vBloc) Therapy: a New Era of Clinical Therapy for Extreme Obesity : Re: Apovian et al. Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial. Obesity Surgery. 2016.

Obes Surg. 2017-2

[9]
Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.

JAMA. 2014-9-3

[10]
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial.

J Obes. 2015

引用本文的文献

[1]
Gastrointestinal devices: common and uncommon foreign bodies.

Abdom Radiol (NY). 2024-8

[2]
Machine learning prediction of emesis and gastrointestinal state in ferrets.

PLoS One. 2019-10-18

[3]
Systematic review on gastric electrical stimulation in obesity treatment.

Expert Rev Med Devices. 2019-10-8

[4]
Laparoscopic vagal nerve blocking device explantation: case series and report of operative technique.

Surg Endosc. 2019-1-10

[5]
Effective weight control via an implanted self-powered vagus nerve stimulation device.

Nat Commun. 2018-12-17

[6]
Interoceptive contributions to healthy eating and obesity.

Curr Opin Psychol. 2017-7-8

本文引用的文献

[1]
Laparoscopic adjustable gastric banding: efficacy and consequences over a 13-year period.

Am J Surg. 2016-7

[2]
Current and emerging medications for overweight or obesity in people with comorbidities.

Diabetes Obes Metab. 2015-11

[3]
Laparoscopic sleeve gastrectomy leads the U.S. utilization of bariatric surgery at academic medical centers.

Surg Obes Relat Dis. 2015

[4]
Use and Outcomes of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Gastric Bypass: Analysis of the American College of Surgeons NSQIP.

J Am Coll Surg. 2015-5

[5]
The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity.

Surg Obes Relat Dis. 2015

[6]
Assessment of perioperative complications following primary bariatric surgery according to the Clavien-Dindo classification: comparison of sleeve gastrectomy and Roux-Y gastric bypass.

Surg Endosc. 2016-1

[7]
Association between bariatric surgery and long-term survival.

JAMA. 2015-1-6

[8]
Is laparoscopic sleeve gastrectomy a lower risk bariatric procedure compared with laparoscopic Roux-en-Y gastric bypass? A meta-analysis.

Am J Surg. 2014-12

[9]
Effectiveness and Safety of Sleeve Gastrectomy, Gastric Bypass, and Adjustable Gastric Banding in Morbidly Obese Patients: a Multicenter, Retrospective, Matched Cohort Study.

Obes Surg. 2015-7

[10]
Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.

JAMA. 2014-9-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索